Fig. 1From: Treatment patterns, healthcare resource utilization, and costs among patients with idiopathic pulmonary fibrosis treated with antifibrotic medications in US-based commercial and Medicare Supplemental claims databases: a retrospective cohort studyPatient selection 1Other interstitial lung diseases are defined as diagnoses of hypersensitivity pneumonitis, diffuse connective tissue disease, rheumatoid arthritis and other inflammatory polyarthropathies, radiation fibrosis, pneumoconiosis, asbestosis, silicosis or talcosis, berylliosis and other inorganic dusts, unspecified pneumoconiosis, and sarcoidosis. HRU, healthcare resource utilizationBack to article page